Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men

Aino Siltaria Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland;b Faculty of Medicine, Pharmacology, University of Helsinki, Helsinki, FinlandCorrespondence[email protected]
View further author information

Teemu J. Murtolaa Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland;c Department of Urology, Tampere University Hospital, Tampere, FinlandView further author information

Josefina Kausza Faculty of Medicine and Health Technology, Tampere University, Tampere, FinlandView further author information

Kirsi Talalad Finnish Cancer Registry, Helsinki, FinlandView further author information

Kimmo Taarie Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandView further author information

Teuvo LJ. Tammelaa Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland;c Department of Urology, Tampere University Hospital, Tampere, FinlandView further author information

Anssi Auvinenf Tampere University, Faculty of Social Sciences, Tampere, FinlandView further author information

show all

Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date